RP

Regeneron Pharmaceuticals, INC.

Concentrated strategyQuality / disciplined sizing

Total reported value

$47.9M

Reporting period: 2026-03-31 · Number of holdings: 2

REGENERON PHARMACEUTICALS, INC. disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $47.9M and a quarterly turnover rate of 35.0%.

Personality snowflake

Concentration
100
Portfolio Stability
34.96
Momentum/Contrarian
50
Sector conviction
0
Diversification
4
Sizing Uniformity
86.1

Recent moves

  • Add NTLA

    0.0%　$14.2M

  • Trim TORCEUR

    0.0%　-$97.4K

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1NTLAIntellia Therapeutics INCStock-Other99.14%+0.65%—
2TORCEURAdicet Bio INCStock-Other0.86%-0.65%—

Holding changes this quarter

Position changes disclosed by Regeneron Pharmaceuticals, INC. for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1NTLAIntellia Therapeutics INC+0.7%—Unchanged
2TORCEURAdicet Bio INC-0.7%—Unchanged

FAQ

What is Regeneron Pharmaceuticals, INC. and what type of investor is it?
Regeneron Pharmaceuticals, INC. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $47.9M, spread across 2 disclosed positions.
What are Regeneron Pharmaceuticals, INC.'s largest equity positions?
Based on the latest 13F filing, Regeneron Pharmaceuticals, INC.'s top holdings by market value are: 1. Intellia Therapeutics INC (NTLA) — $47.5M (99.1%) 2. Adicet Bio INC (TORCEUR) — $412.1K (0.9%)
What changes did Regeneron Pharmaceuticals, INC. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Regeneron Pharmaceuticals, INC. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Regeneron Pharmaceuticals, INC. focus on?
Sector breakdown data is not yet available for Regeneron Pharmaceuticals, INC.. Check back after the next 13F processing cycle.